Deregulation of SPL metabolizing genes and the consequent alteration in SPL species is associated with numerous human diseases, including neurological disorders, skin diseases, and cancer (Dunn et al, 2019; Pan et al, 2023). This evidence concerns the gene SGPL1 and cancer.